174 related articles for article (PubMed ID: 17385308)
1. Findings of fluorine-18-FDG PET in extranodal origin lymphoma--in three cases of diffuse large B cell type lymphoma.
Nihashi T; Hayasaka K; Itou T; Ito K; Kato R; Okae T; Ishigaki T
Ann Nucl Med; 2006 Dec; 20(10):689-93. PubMed ID: 17385308
[TBL] [Abstract][Full Text] [Related]
2. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M
PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of post-treatment
An YS; Yoon JK; Lee SJ; Jeong SH; Lee HW
Eur Radiol; 2016 Dec; 26(12):4632-4639. PubMed ID: 27193777
[TBL] [Abstract][Full Text] [Related]
6. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I
Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
[TBL] [Abstract][Full Text] [Related]
8. Standardized uptake value for (18)F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with diffuse large B-cell lymphoma.
Akkas BE; Vural GU
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):148-52. PubMed ID: 24094371
[TBL] [Abstract][Full Text] [Related]
9. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET/MRI findings of primary breast lymphoma in two cases: FDG PET/MRI findings of primary breast lymphoma.
Kong EJ; Cho IH
Clin Imaging; 2015; 39(4):682-4. PubMed ID: 25748090
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.
Paes FM; Kalkanis DG; Sideras PA; Serafini AN
Radiographics; 2010 Jan; 30(1):269-91. PubMed ID: 20083598
[TBL] [Abstract][Full Text] [Related]
12. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.
Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY
Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758
[TBL] [Abstract][Full Text] [Related]
13. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma.
Sakurai M; Toyama T; Kikuchi T; Kato J; Shimizu T; Koda Y; Karigane D; Yamane Y; Abe R; Yamazaki R; Nakazato T; Nakahara T; Jinzaki M; Okamoto S; Mori T
Int J Hematol; 2018 Feb; 107(2):194-200. PubMed ID: 28994017
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
Bai X; Codreanu I; Kaplan SL; Servaes S; Zhuang H
Clin Nucl Med; 2015 Apr; 40(4):360-3. PubMed ID: 25608171
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
Kumar R; Xiu Y; Dhurairaj T; Yu JQ; Alavi A; Zhuang H
Clin Nucl Med; 2005 Apr; 30(4):246-8. PubMed ID: 15764881
[TBL] [Abstract][Full Text] [Related]
17. Intravascular Large B-Cell Lymphoma Identified by PET/CT.
Liu W; Liu M; Guan M; Huang J; Xie P
Clin Nucl Med; 2023 Jun; 48(6):528-529. PubMed ID: 37019128
[TBL] [Abstract][Full Text] [Related]
18. PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma.
Yildirim-Poyraz N; Ozdemir E; Basturk A; Kilicarslan A; Turkolmez S
Clin Nucl Med; 2015 Feb; 40(2):141-5. PubMed ID: 24873799
[TBL] [Abstract][Full Text] [Related]
19. Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.
Tang J; Salloum D; Carney B; Brand C; Kossatz S; Sadique A; Lewis JS; Weber WA; Wendel HG; Reiner T
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7441-E7449. PubMed ID: 28827325
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
